JNJ: Bull Flag detected on 3 Sep 2026

A bull flag pattern has formed in JNJ following recent strength, with the flag structure taking shape near resistance at 273.56. Current price of 275.21 sits just above this level, only 2.08% below the 52-week high of 280.51. The structure score of 14.1/15 reflects a well-defined flagpole and consolidation, while the breakout score of 12.4/13 signals strong directional momentum ready to resume. Volume ratio of 1.23x average confirms above-average participation. With an overall pattern quality score of 78/98 and a win probability of 73.85%, this setup presents above-average technical merit for trend continuation.

JNJ delivered Q2 2026 earnings of $2.90 per share, beating consensus of $2.84, with revenue of $25.31 billion versus $25.06 billion expected—marking a 6.6% year-over-year revenue increase. The company also beat prior-year EPS of $2.77, demonstrating operational momentum. Management raised full-year 2026 guidance to $11.60–$11.75 per share, aligning with analyst consensus of $11.61. The Board increased the quarterly dividend to $1.34 per share, payable September 8, 2026, signaling confidence in cash generation. JNJ is scheduled to present at the Deutsche Bank 2026 Healthcare Summit on September 17th, providing near-term visibility for investor commentary. The FDA approved IMAAVY® (nipocalimab-aahu) in August 2026 as the first-ever treatment for warm autoimmune hemolytic anemia, representing a landmark advancement. Healthcare sector regime is bullish (0.57 score), supporting positive backdrop.

A successful breakout from this bull flag would confirm continuation above the 273.56 resistance level, with the measured move target at 284.29—a gain of approximately 3.3% from current price. Historical data on bull flags shows bullish breakouts succeed roughly 73.85% of the time when volume confirms the move. Invalidation occurs on a close below key support at 249.22, which represents a 9.5% downside risk. The pattern suggests upside potential to near the recent highs, with modest risk-reward skew favoring buyers if breakout confirmation arrives on volume spike above the recent 7.91M share count.

Technical setup shows RSI at 63.3, nearing overbought territory (70), which could invite profit-taking near resistance. ATR of 5.55 ($2.02% of price) reflects elevated intraday volatility that may whipsaw breakout attempts. Sector regime is neutral (0.09 score), limiting macro tailwinds despite healthcare sector strength. Back-to-back investor conferences on September 9th and 17th carry headline risk—unexpected commentary could disrupt pattern momentum. Beta of 0.18 suggests low sensitivity to market drawdowns, but the upcoming dividend payment date and earnings guidance reiteration increase event risk. Low volume on the flag consolidation (1.23x average) raises concern about breakout conviction; pattern needs substantial volume confirmation to validate the move toward 284.29 target.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.